−390 KRW
−2.30 B KRW
53.75 B KRW
69.53 M
About HLB THERAPEUTICS
Sector
Industry
CEO
Ki-Hong An
Website
Headquarters
Seongnam-si
Founded
2000
ISIN
KR7115450009
FIGI
BBG000QCN543
HLB Therapeutics Co., Ltd. engages in the development and sale of vaccines and manufacture of electronic parts. It operates through the following business divisions: Vaccine, Electronics, and Bio division. The Vaccine business division engages in the wholesale of flu vaccines and other vaccines. The Electronics business division manufactures motors, pumps, and electronic components. The Bio business division develops ophthalmic disease treatment, skin wound treatment and glioblastoma treatment. The company was founded on June 7, 2000 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 115450 is 10,690 KRW — it has increased by 0.19% in the past 24 hours. Watch HLB THERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HLB THERAPEUTICS stocks are traded under the ticker 115450.
115450 stock has risen by 7.87% compared to the previous week, the month change is a 10.21% rise, over the last year HLB THERAPEUTICS has showed a 162.81% increase.
115450 reached its all-time high on Apr 9, 2018 with the price of 26,560 KRW, and its all-time low was 860 KRW and was reached on Jul 24, 2013. View more price dynamics on 115450 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
115450 stock is 5.53% volatile and has beta coefficient of 1.67. Track HLB THERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is HLB THERAPEUTICS there?
Today HLB THERAPEUTICS has the market capitalization of 853.09 B, it has increased by 3.08% over the last week.
Yes, you can track HLB THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
115450 net income for the last quarter is −2.56 B KRW, while the quarter before that showed −22.27 B KRW of net income which accounts for 88.49% change. Track more HLB THERAPEUTICS financial stats to get the full picture.
No, 115450 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 92.00 employees. See our rating of the largest employees — is HLB THERAPEUTICS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HLB THERAPEUTICS EBITDA is −1.99 B KRW, and current EBITDA margin is −0.68%. See more stats in HLB THERAPEUTICS financial statements.
Like other stocks, 115450 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HLB THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HLB THERAPEUTICS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HLB THERAPEUTICS stock shows the buy signal. See more of HLB THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.